235 related articles for article (PubMed ID: 14996525)
1. Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial.
Shi L; Namjoshi MA; Swindle R; Yu X; Risser R; Baker RW; Tohen M
Clin Ther; 2004 Jan; 26(1):125-34. PubMed ID: 14996525
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial.
Detke HC; DelBello MP; Landry J; Usher RW
J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):217-24. PubMed ID: 25721187
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
[TBL] [Abstract][Full Text] [Related]
4. Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.
Keck PE; Corya SA; Altshuler LL; Ketter TA; McElroy SL; Case M; Briggs SD; Tohen M
J Clin Psychiatry; 2005 May; 66(5):611-6. PubMed ID: 15889948
[TBL] [Abstract][Full Text] [Related]
5. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.
Brown EB; McElroy SL; Keck PE; Deldar A; Adams DH; Tohen M; Williamson DJ
J Clin Psychiatry; 2006 Jul; 67(7):1025-33. PubMed ID: 16889444
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico.
Tamayo JM; Sutton VK; Mattei MA; Diaz B; Jamal HH; Vieta E; Zarate CA; Fumero I; Tohen M
J Clin Psychopharmacol; 2009 Aug; 29(4):358-61. PubMed ID: 19593175
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression.
Brown E; Dunner DL; McElroy SL; Keck PE; Adams DH; Degenhardt E; Tohen M; Houston JP
Int J Neuropsychopharmacol; 2009 Jul; 12(6):773-82. PubMed ID: 19079815
[TBL] [Abstract][Full Text] [Related]
8. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.
Corya SA; Perlis RH; Keck PE; Lin DY; Case MG; Williamson DJ; Tohen MF
J Clin Psychiatry; 2006 May; 67(5):798-806. PubMed ID: 16841630
[TBL] [Abstract][Full Text] [Related]
9. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.
Zanarini MC; Frankenburg FR; Parachini EA
J Clin Psychiatry; 2004 Jul; 65(7):903-7. PubMed ID: 15291677
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of depressive symptom improvement in bipolar I depressed patients.
Williamson D; Brown E; Perlis RH; Ahl J; Baker RW; Tohen M
J Affect Disord; 2006 Jun; 92(2-3):261-6. PubMed ID: 16563521
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
[TBL] [Abstract][Full Text] [Related]
12. Asenapine treatment and health-related quality of life in patients experiencing bipolar I disorder with mixed episodes: post-hoc analyses of pivotal trials.
Michalak EE; Guiraud-Diawara A; Sapin C
Curr Med Res Opin; 2014 Apr; 30(4):711-8. PubMed ID: 24329543
[TBL] [Abstract][Full Text] [Related]
13. Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression.
Perlis RH; Adams DH; Fijal B; Sutton VK; Farmen M; Breier A; Houston JP
J Clin Psychiatry; 2010 May; 71(5):599-605. PubMed ID: 20021991
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic evaluation of olanzapine + fluoxetine for the treatment of bipolar depression.
Dubovsky SL
Expert Opin Drug Metab Toxicol; 2013 Feb; 9(2):207-14. PubMed ID: 23294052
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.
Corya SA; Williamson D; Sanger TM; Briggs SD; Case M; Tollefson G
Depress Anxiety; 2006; 23(6):364-72. PubMed ID: 16710853
[TBL] [Abstract][Full Text] [Related]
16. Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction.
Amsterdam JD; Shults J
J Affect Disord; 2005 Jul; 87(1):121-30. PubMed ID: 15923042
[TBL] [Abstract][Full Text] [Related]
17. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine/Fluoxetine (Symbyax) for bipolar depression.
Med Lett Drugs Ther; 2004 Mar; 46(1178):23-4. PubMed ID: 15037858
[No Abstract] [Full Text] [Related]
19. Quality of life in children and adolescents with bipolar I depression treated with olanzapine/fluoxetine combination.
Walker DJ; DelBello MP; Landry J; D'Souza DN; Detke HC
Child Adolesc Psychiatry Ment Health; 2017; 11():34. PubMed ID: 28706563
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance.
Shelton RC; Williamson DJ; Corya SA; Sanger TM; Van Campen LE; Case M; Briggs SD; Tollefson GD
J Clin Psychiatry; 2005 Oct; 66(10):1289-97. PubMed ID: 16259543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
